Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Mail Ru Group Gdr (MLRUY) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Mail Ru Group Gdr MLRUY
Board Mod:
Add me as mod
Asst Mods:
Last Post: 01/17/2012 12:57:10 AM
Board Marks: 0
Posts Today: 0
Board Views Today: 3
Mail Ru Group Gdr (OTCMRKTS: MLRUY) Stock Message Board
MLRUY Company Profile
MLRUY Time & Sales
MLRUY Recent News
MLRUY Filings
MLRUY Financials
MLRUY Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
Be the first to post on Mail Ru Group Gdr MLRUY
Recent Articles
How to Find the Perfect New Home in Your Desired Location
Discover RubyReels: Australia’s Next Top Online Casino in 2025
DeLeion Capital Seizes Opportunities in Crypto Landscape
EU Takes Bold Steps to Secure Rare Earth Supply Chain
What Investors Need to Know About Jasper Therapeutics Class Action
KBR Investors Urged to Act Ahead of Class Action Deadline
Trump's Rally in New Jersey: A Clash of Political Titans
Discover the Excellence of Kratom Bird's Online Shopping Experience
Avacta Unveils Promising Dual Payload Data from Cancer Therapies
Exploring the Breakthrough Potential of BBO-10203 in Cancer Treatment
AlphaTON Capital and Cyncado Therapeutics Advance Cancer Research
Investor Insights: Key Stocks Sparking Discussions This Week
Novartis Unveils Promising Results in Autoimmune Research
Innovative CLN-978 Shows Promise for Autoimmune Treatments
Innovative Advances in Rare Disease Care Highlighted by Sobi
Cytokinetics Faces Class Action: What Investors Need to Know
Innovative B Cell Treatment CLN-978 Shows Promising Data
Exploring Elon Musk's Vision for a Future with Universal High Income
The Digital Hotelier's Bold Move into the Americas Market
BIMZELX® Insights: Three-Year Results in Rheumatology Showcase Progress
Innovative CAR-Treg Therapy QEL-005 Set for Major Reveal
KYV-101: A Promising New Therapy Option for Rheumatoid Arthritis
Sify Technologies Delivers Strong Quarter with Robust Growth Metrics
Sify Technologies Q2 FY 2025-26 Results: Growth Insights
Quantum Corporation Class Action: Key Updates and Next Steps
MoonBull ($MOBU) Achieves Presale Milestone and Engages Community
Understanding Investor Rights: Telix Pharmaceuticals Class Action Details
Unveiling Taiwan's Historical Legacy Through a Personal Journey
Unlocking America's Hidden Mineral Wealth and Its Impact
Phathom Pharmaceuticals' VOQUEZNA® Shows Promising GERD Relief
Invest in Your Future: Class Action Details on V.F. Corp
LiTime Unveils Innovative Lithium Solutions for Landscaping
Grant Cardone Explores Future of Investments in Bitcoin and Real Estate
MOVA Launches Innovative Smart Outdoor Tech at Equip Exposition
Discover How MENU – ORDER AI is Transforming Healthy Dining
Mutuum Finance Gears Up for V1 Protocol Launch: What to Expect
Stock Movements: Beyond Meat, Intel, and Newmont's Earnings Impact
Unlocking Vehicle Security with the LAMTTO DC22 Dash Camera
Mutuum Finance Excels with Significant Funding as It Prepares for V1 Launch
Uniting Hearts and Homes: A Mission to Save Pets in Miami
Reviving Taiwan's History: A Journey Through Time and Sacrifice
How a Heist Sparked a Creative Marketing Campaign for Böcker
Exciting Week in Crypto: Insights from Coinbase and Market Movements
Deepinder Goyal's $25 Million Vision for Human Longevity
Impact of Trump Policies on Pennsylvania's Trade with Canada
Concerns Rise Over Tesla's Future as BYD Outpaces Competition
Revolutionary Phase 3 Trial Data Shows Promise for ITM-11
Major Changes at X: Advertising Chief Nitti Departs Company
Cardiovalve Targets CE Mark for Advanced Heart Valve Solutions
Milestone Achieved: Cardiovalve Completes TARGET Study Enrollment